Biotronik today announced a strategic shift that includes the divestiture of its Vascular Intervention (VI) business to Teleflex.
MyChesCo on MSN18d
Teleflex Acquires BIOTRONIK’s Vascular Intervention Business in $760 Million DealTeleflex Incorporated (NYSE: TFX) has announced its agreement to acquire BIOTRONIK’s Vascular Intervention business in a transaction valued at approximately €760 million. With this strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback